Manic Fringe Promotes Endothelial-to-mesenchymal Transition Mediated by the Notch Signalling Pathway During Heart Valve Development

Overview

Journal J Mol Med (Berl)

Specialty General Medicine

Date 2024 Nov 11

PMID 39528804

Authors

Junjie Yang

Zhi Wang

Yue Zhou

Shiwei Jiang

Xiji Qin

Zhikang Xu

Yu Wang

Mengying Zuo

Zhuo Meng

Sun Chen

Qingjie Wang

Jian Wang

Kun Sun

Affiliations

Soon will be listed here.

Abstract

A fundamental event in the formation of heart valves involves the transformation of endocardial cells within the outflow tract (OFT) and atrioventricular canal (AVC) cushions through a process known as endothelial-to-mesenchymal transition (EndMT). Aberrant EndMT is a primary cause of congenital valvular malformations. Manic Fringe (MFNG) has been previously associated with cardiovascular development, although its role in heart valve development remains underexplored. In this study, we seek to enhance our understanding of MFNG's involvement in valve formation and its association with EndMT. Staining results of histological section revealed the expression of MFNG in the AVC and OFT from embryonic day 9.5 to 10.5 (E9.5-E10.5), when EndMT takes place. Cellular data demonstrated that MFNG exerts a positive regulatory influence on the EndMT process, promoting endothelial cell (EC) migration by enhancing the activity of the Notch signalling pathway. MFNG knockdown mediated by antisense morpholino oligonucleotides (MO) injection caused abnormal development of the heart and valves in zebrafish. Furthermore, through whole-exome sequencing (WES), we identified a heterozygous MFNG mutation in patients diagnosed with tetralogy of Fallot-pulmonary valve stenosis (TOF-PS). Cellular and molecular assays confirmed that this deleterious mutation reduced MFNG expression and hindered the EndMT process. In summary, our study verifies that MFNG plays a role in promoting EndMT mediated by the Notch signalling pathway during the heart and valve development. The MFNG deleterious variant induces MFNG loss of function, potentially elucidating the underlying molecular mechanisms of MFNG's involvement in the pathogenesis of congenital heart valve defects. These observations contribute to our current genetic understanding of congenital heart valve disease and may provide a potential target for prenatal diagnosis and treatment. KEY MESSAGES: Our examination revealed, for the first time, that MFNG exhibited high expression levels during EndMT of heart valve development in mice. Our findings provide compelling evidence that MFNG plays a role in promoting EndMT mediated by the Notch signalling pathway. Our results identified, for the first time, a deleterious MFNG p. T77M variant that inhibited the EndMT process by downregulating the activity of the Notch signalling pathway, thereby preventing the normal valve formation. MFNG may serve as an early diagnostic marker and an effective therapeutic target for the clinical treatment of congenital heart valve defects.

Citing Articles

TRIM28 functions as SUMO ligase to SUMOylate TRAF6 and regulate NF-κB activation in HBV-replicating cells.

Yang Y, Wang T, Fu Y, Li X, Yu F Hepatol Int. 2025; .

PMID: 39920527 DOI: 10.1007/s12072-025-10779-6.

References

Fishman M, Chien K . Fashioning the vertebrate heart: earliest embryonic decisions. Development. 1997; 124(11):2099-117. DOI: 10.1242/dev.124.11.2099. View

Bi Y, Yang Z, Jin M, Zhai K, Wang J, Mao Y . ERp44 is required for endocardial cushion development by regulating VEGFA secretion in myocardium. Cell Prolif. 2022; 55(3):e13179. PMC: 8891561. DOI: 10.1111/cpr.13179. View

Okajima T, Irvine K . Regulation of notch signaling by o-linked fucose. Cell. 2003; 111(6):893-904. DOI: 10.1016/s0092-8674(02)01114-5. View

Foffa I, Ait Ali L, Panesi P, Mariani M, Festa P, Botto N . Sequencing of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes in familial cases of bicuspid aortic valve. BMC Med Genet. 2013; 14:44. PMC: 3637327. DOI: 10.1186/1471-2350-14-44. View

Moloney D, Panin V, Johnston S, Chen J, Shao L, Wilson R . Fringe is a glycosyltransferase that modifies Notch. Nature. 2000; 406(6794):369-75. DOI: 10.1038/35019000. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Borden W . Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2012; 127(1):e6-e245. PMC: 5408511. DOI: 10.1161/CIR.0b013e31828124ad. View

LaHaye S, Lincoln J, Garg V . Genetics of valvular heart disease. Curr Cardiol Rep. 2014; 16(6):487. PMC: 4531840. DOI: 10.1007/s11886-014-0487-2. View

Galvin K, Donovan M, Lynch C, Meyer R, Paul R, Lorenz J . A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet. 2000; 24(2):171-4. DOI: 10.1038/72835. View

Xiang R, Fan L, Huang H, Cao B, Li X, Peng D . A novel mutation of GATA4 (K319E) is responsible for familial atrial septal defect and pulmonary valve stenosis. Gene. 2014; 534(2):320-3. View

10.

Sethi M, Buettner F, Krylov V, Takeuchi H, Nifantiev N, Haltiwanger R . Identification of glycosyltransferase 8 family members as xylosyltransferases acting on O-glucosylated notch epidermal growth factor repeats. J Biol Chem. 2009; 285(3):1582-6. PMC: 2804315. DOI: 10.1074/jbc.C109.065409. View

11.

Travisano S, Oliveira V, Prados B, Grego-Bessa J, Pineiro-Sabaris R, Bou V . Coronary arterial development is regulated by a Dll4-Jag1-EphrinB2 signaling cascade. Elife. 2019; 8. PMC: 6917494. DOI: 10.7554/eLife.49977. View

12.

Laforest B, Andelfinger G, Nemer M . Loss of Gata5 in mice leads to bicuspid aortic valve. J Clin Invest. 2011; 121(7):2876-87. PMC: 3223824. DOI: 10.1172/JCI44555. View

13.

Garside V, Chang A, Karsan A, Hoodless P . Co-ordinating Notch, BMP, and TGF-β signaling during heart valve development. Cell Mol Life Sci. 2012; 70(16):2899-917. PMC: 4996658. DOI: 10.1007/s00018-012-1197-9. View

14.

Pierpont M, Basson C, Benson Jr D, Gelb B, Giglia T, Goldmuntz E . Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of.... Circulation. 2007; 115(23):3015-38. DOI: 10.1161/CIRCULATIONAHA.106.183056. View

15.

McKellar S, Tester D, Yagubyan M, Majumdar R, Ackerman M, Sundt 3rd T . Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2007; 134(2):290-6. DOI: 10.1016/j.jtcvs.2007.02.041. View

16.

Combs M, Yutzey K . Heart valve development: regulatory networks in development and disease. Circ Res. 2009; 105(5):408-21. PMC: 2777683. DOI: 10.1161/CIRCRESAHA.109.201566. View

17.

Paige S, Thomas S, Stoick-Cooper C, Wang H, Maves L, Sandstrom R . A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell. 2012; 151(1):221-32. PMC: 3462257. DOI: 10.1016/j.cell.2012.08.027. View

18.

Okubo A, Miyoshi O, Baba K, Takagi M, Tsukamoto K, Kinoshita A . A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet. 2004; 41(7):e97. PMC: 1735839. DOI: 10.1136/jmg.2004.018895. View

19.

Mohamed S, Aherrahrou Z, Liptau H, Erasmi A, Hagemann C, Wrobel S . Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem Biophys Res Commun. 2006; 345(4):1460-5. DOI: 10.1016/j.bbrc.2006.05.046. View

20.

Piera-Velazquez S, Jimenez S . Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases. Physiol Rev. 2019; 99(2):1281-1324. PMC: 6734087. DOI: 10.1152/physrev.00021.2018. View